MAPT and Alzheimer disease: We demonstrated that Tau destabilization from MTs and its increased amount as a soluble protein not associated to MTs, typically occurring during AD progression, alters the expression of synaptic genes associated with AD pathology (Wang and Mandelkow, 2016; Han et al., 2017; Siano et al., 2019b).